Medicare Enrolled

Dr. Gary Schiller, MD

Hematology & Oncology · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
200 MEDICAL PLAZA, Los Angeles, CA 90095
3108255513
In practice since 2006 (19 years)
NPI: 1851311930 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schiller from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schiller? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schiller

Dr. Gary Schiller is a hematology & oncology specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Schiller performed 1,550 Medicare services across 535 unique beneficiaries.

Between the years covered by Open Payments, Dr. Schiller received a total of $283,219 from 38 pharmaceutical and/or device companies across 255 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schiller is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 44% volume in CA $283,219 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,550
Medicare services
Top 44% in CA for hematology & oncology
535
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~82 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,054 $53 $508
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
253 $67 $470
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
125 $61 $858
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
43 $28 $354
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
38 $109 $1,085
Hospital discharge day management, 30 minutes or less
This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less.
19 $70 $356
Bone marrow biopsy and aspiration
A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions.
18 $65 $856
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$283,219
Total received (2018-2024)
Avg $40,460/year across 7 years
Top 4% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
255
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$235,668 (83.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$45,500 (16.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,051 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$11,662
2023
$41,795
2022
$37,879
2021
$30,580
2020
$41,365
2019
$66,096
2018
$53,842

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Rigel Pharmaceuticals, Inc.
$7,928
E.R. Squibb & Sons, L.L.C.
$2,076
Karyopharm Therapeutics Inc.
$815
Eurofins Viracor, LLC
$283
Janssen Biotech, Inc.
$148
AstraZeneca Pharmaceuticals LP
$135
Astellas Pharma US Inc
$118
Celgene Corporation
$51
Amgen Inc.
$45
Gamida Cell Inc.
$43
PFIZER INC.
$21
Top 3 companies account for 92.8% of 2024 payments
All-time payments by company (2018-2024) ›
Karyopharm Therapeutics Inc.
$23,646
Celgene Corporation
$23,551
Jazz Pharmaceuticals Inc.
$23,119
JAZZ PHARMACEUTICALS INC.
$21,378
Astellas Pharma US Inc
$19,273
E.R. Squibb & Sons, L.L.C.
$19,061
Kite Pharma, Inc.
$18,043
Amgen Inc.
$15,984
Agios Pharmaceuticals, Inc.
$15,977
Rigel Pharmaceuticals, Inc.
$15,910
SANOFI-AVENTIS U.S. LLC
$13,241
Stemline Therapeutics Inc.
$11,490
GENZYME CORPORATION
$10,900
Blueprint Medicines Corporation
$6,045
Incyte Corporation
$5,513
PFIZER INC.
$5,458
SANOFI US SERVICES INC.
$4,780
AstraZeneca Pharmaceuticals LP
$4,605
Janssen Biotech, Inc.
$4,523
Novartis Pharmaceuticals Corporation
$4,049
Pharmacyclics LLC, An AbbVie Company
$3,635
AbbVie Inc.
$3,613
GlaxoSmithKline, LLC.
$3,150
Innate Pharma, Inc
$2,400
NOVARTIS PHARMACEUTICALS CORPORATION
$2,000
Gilead Sciences, Inc.
$760
Eurofins Viracor, LLC
$283
Genentech USA, Inc.
$278
EUSA Pharma (US) LLC
$225
Daiichi Sankyo Inc.
$62
CTI BioPharma Corp.
$50
Servier Pharmaceuticals LLC
$43
Gamida Cell Inc.
$43
Janssen Research & Development, LLC
$40
Adaptive Biotechnologies Corporation
$31
Apellis Pharmaceuticals, Inc.
$25
ABBVIE INC.
$23
Merck Sharp & Dohme Corporation
$13
Top 3 companies account for 24.8% of all-time payments
Associated products mentioned in payments ›
AYVAKIT · Blincyto · CALQUENCE · DARZALEX · DAURISMO · ELITEK · ELZONRIS · Empaveli · IMBRUVICA · ISATUXIMAB · Imbruvica · JAKAFI · Kyprolis · LUMOXITI · Lumoxiti · MONJUVI · MYLOTARG · NO PRODUCT DISCUSSED · OMISIRGE · ONUREG · OXBRYTA · PREVYMIS · PYRUKYND · Pomalyst · REBLOZYL · REZUROCK · RYDAPT · Revlimid · Rezlidhia · Sylvant · THYMOGLOBULIN · TIBSOVO · Tecartus · VENCLEXTA · VYXEOS · Vonjo · XOSPATA · XPOVIO · Xospata · Yescarta · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (83%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for hematology & oncology in CA.

Looking for a hematology & oncology specialist in Los Angeles?
Compare hematology & oncology specialists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
354
Per 100K population
3.6
County median income
$87,760
Nearest hospital
RONALD REAGAN UCLA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Schiller is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 4% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Schiller experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Schiller performed 1,054 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schiller receive payments from pharmaceutical companies?
Yes. Dr. Schiller received a total of $283,219 from 38 companies across 255 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schiller's costs compare to other hematology & oncology specialists in Los Angeles?
Dr. Schiller's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schiller) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →